Microbiology and Immunology
Erwann Loret obtained is Ph. D. in France in February 1990, then he went to USA for a first post-doc in the department of biophysics and biochemistry at Oregon State University, followed by a second post-doc in the department of chemistry at the University of California, Davis. He was hired in 1992 in the Centre National de Recherche Scientifique(CNRS), which is the main French national agency for scientific research. Erwann Loret obtained the GlaxoSmith Kline Drug Discovery and Development Award from an American scientific committee for his contribution to HIV research, the Medail of honor from the Aix Marseille University (AMU) and the French National Institute for Intellectual Properties Award. He is heading the ETRAV lab that is the only lab working on HIV at Marseille. He is member of the Editorial Board of scientific journals and author and co author of 60 scientific publications with a high impact factor and five patents with PCT. His main field of interest is related to the HIV-1 Tat proteins. He is the inventor of the Tat Oyi vaccine and coordinated the EVATAT clinical trial.
Vaccines and Immunology